TP53 Mutations Emerge as a Critical Biomarker in Penile Cancer, Superseding Human Papillomavirus Status

Affiliations

• ¹ Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA.
• ² Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
• ³ Vita-Salute San Raffaele University, Milan, Italy; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: necchi.andrea@hsr.it.
• ⁴ Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA. Electronic address: philippe.spiess@moffitt.org.